What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Mitchell S. Cairo mostly deals with Internal medicine, Surgery, Transplantation, Oncology and Lymphoma.
Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology.
His Surgery research is multidisciplinary, incorporating elements of Lower risk and Intensive care medicine.
His research in Transplantation intersects with topics in Leukemia, Immunology, Cord blood and Histocompatibility.
His Oncology study combines topics in areas such as Lymphoblastic lymphoma, Hematology, Diffuse large B-cell lymphoma, Anaplastic large-cell lymphoma and Prospective cohort study.
His work deals with themes such as Young adult, Cancer and Hazard ratio, which intersect with Lymphoma.
His most cited work include:
- Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors (793 citations)
- Tumour lysis syndrome: new therapeutic strategies and classification (605 citations)
- A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome (502 citations)
What are the main themes of his work throughout his whole career to date?
Mitchell S. Cairo focuses on Internal medicine, Transplantation, Immunology, Oncology and Lymphoma.
He has included themes like Gastroenterology and Surgery in his Internal medicine study.
Within one scientific family, Mitchell S. Cairo focuses on topics pertaining to Disease under Transplantation, and may sometimes address concerns connected to Cell.
His Immunology research includes themes of Molecular biology and Cytotoxic T cell.
His Oncology research is multidisciplinary, relying on both Young adult, Hematology, Hodgkin lymphoma, Myeloid leukemia and Acute leukemia.
His Lymphoma research includes themes of Cancer and Cancer research.
He most often published in these fields:
- Internal medicine (49.49%)
- Transplantation (32.60%)
- Immunology (32.16%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (49.49%)
- Transplantation (32.60%)
- Oncology (28.49%)
In recent papers he was focusing on the following fields of study:
Mitchell S. Cairo mainly focuses on Internal medicine, Transplantation, Oncology, Cancer research and Lymphoma.
Myeloid is closely connected to Gastroenterology in his research, which is encompassed under the umbrella topic of Internal medicine.
His Transplantation research is multidisciplinary, incorporating elements of Leukemia, Stem cell, Disease and Hazard ratio.
Mitchell S. Cairo studied Oncology and Fludarabine that intersect with Busulfan and Total body irradiation.
Mitchell S. Cairo interconnects Cytotoxic T cell, Granzyme B, Interleukin 15, Rituximab and CD20 in the investigation of issues within Cancer research.
The Rituximab study combines topics in areas such as Chemotherapy and Antibody-dependent cell-mediated cytotoxicity.
Between 2017 and 2021, his most popular works were:
- Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors (41 citations)
- Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission (32 citations)
- Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure. (28 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His scientific interests lie mostly in Internal medicine, Oncology, Lymphoma, Transplantation and Cancer research.
As part of his studies on Internal medicine, he often connects relevant subjects like Gastroenterology.
His Oncology research is multidisciplinary, incorporating perspectives in Melphalan, Rituximab, Chemoimmunotherapy, Diffuse large B-cell lymphoma and Follicular lymphoma.
His studies in Lymphoma integrate themes in fields like Young adult, Pediatrics and Chemotherapy.
His Transplantation research incorporates elements of Cytarabine, Leukemia and Sibling.
His research integrates issues of Cell growth, Carcinogenesis, NKG2D, Phosphorylation and Immunotherapy in his study of Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
